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Abstract
Circadian rhythms influence daily molecular oscillations in gene/protein
expression and aspects of biology and physiology, including behaviour,
body temperature and sleep–wake cycles. These circadian rhythms have
been associated with a number of metabolic, immune and microbial
changes that correlate with health and susceptibility to disease, including
infection. While light is the main inducer of circadian rhythms, other fac-
tors, including the microbiota, can have important effects on peripheral
rhythms. The microbiota have been of significant interest to many investi-
gators over the past decade, with the development of molecular tech-
niques to identify large numbers of species and their function. These
studies have shown microbial associations with disease susceptibility, and
some of these have demonstrated that alterations in microbiota cause dis-
ease. Microbial circadian oscillations impact host metabolism and immu-
nity directly and indirectly. Interestingly, microbial oscillations also
regulate host circadian rhythms, and the host circadian rhythms in turn
modulate microbial composition. Thus, it is of considerable interest and
importance to understand the crosstalk between circadian rhythms and
microbiota and especially the microbial influences on the host. In this
review, we aim to discuss the role of circadian microbial oscillations and
how they influence host immunity. In addition, we discuss how host cir-
cadian rhythms can also modulate microbial rhythms. We also discuss
potential connections between microbes and circadian rhythms and how
these may be used therapeutically to maximize clinical success.
Keywords: circadian rhythms; immune system; Microbiota; pattern recog-
nition receptors.
INTRODUCTION
The microbiota and the immune system have co-evolved
to maintain homeostasis and help protect our bodies
from pathogens.1,2 Approximately 1000 microbial species
reside in the human intestines, encoding a metagenome
of trillions of genes, which are over 100 times greater
than the human genome, with millions of unique genes.3-
6 The microbiota influence many important aspects of
host physiology, including modulating development, mat-
uration and functions of the innate and adaptive immune
systems. This has been highlighted in studies with gnoto-
biotic (mice with a defined microbial community) or
germ-free (GF; no microbiota) animals, which have a
more na€ıve immune system, particularly in mucosa-asso-
ciated lymphoid tissues.7 The microbial composition can
Abbreviations: BMAL1, Brain and muscle ARNT-like 1; CLOCK, Circadian locomotor output cycles protein kaput; CRY, Cryp-
tochrome; DCs, Dendritic cells; GF, Germ-free; GM-CSF, Granulocyte–macrophage colony-stimulating factor; HIF, Hypoxia-in-
ducible factor; IECs, Intestinal epithelial cells; LPS, Lipopolysaccharides; MYD88, Myeloid differentiation primary response gene
88; NFIL3, Nuclear factor, Interleukin-3 regulated; Nod2, Nucleotide oligomerization domain-containing protein 2; PAMPs,
Pathogen-associated molecular patterns; PER, Period circadian protein homologue; PPARa, Peroxisome proliferator-activated
receptor alpha; PRRs, Pattern recognition receptors; ROR, Retinoic acid receptors; RORE, ROR response element; SCFA, Short-
chain fatty acids; SCN, Suprachiasmatic nucleus; SPF, Specific pathogen-free; TLRs, Toll-like receptors; TRIF, TIR-domain-con-
taining adaptor-inducing interferon-b; ZT, Zeitgeber
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be modulated by a number of factors, including age, diet
and host health (Figure 1). Disruption of the balance
between the immune system and the microbiota pro-
motes dysbiosis and increases susceptibility to various
health issues including cancers, infections, autoimmune
diseases and metabolic disorders.8-11 Furthermore, micro-
biota can also modulate responses to immunotherapy, for
example anti-PD1 treatment in cancer.12,13
Circadian rhythms, referring to daily oscillations in
gene activation and repression, as well as biological and
physiological processes, can be induced by light, hor-
mones, metabolic cues and the microbiota. The circadian
rhythm influences immunity, microbial dynamics and
host metabolism. Circadian rhythms are controlled by
highly regulated transcription/translation feedback loops
(Figure 2) and are reviewed in more detail elsewhere.14
Light is the main inducer of circadian rhythms via activa-
tion of the suprachiasmatic nucleus (SCN).15,16 The SCN
comprises ~20,000 specialized neurons within the
hypothalamus, which control and co-ordinate circadian
rhythms in exercise, hormones, body temperature and
eating. However, additional peripheral rhythms are
needed for fine-tuning the circadian clock, enhancing
responses to environmental cues, for example food intake,
body temperature and the microbiota. These peripheral
rhythms differ from central circadian rhythms in that
individual circadian clock components differentially mod-
ulate both types of rhythms. Furthermore, peripheral
rhythms are subject to different influences which reset
individual rhythms and control their outputs. Genes con-
trolling these peripheral rhythms in different tissues also
control individual cellular physiology.17,18 Thus, periph-
eral rhythms temporally control many aspects of metabo-
lism, including glucose homeostasis, lipogenesis and
xenobiotic detoxification.19-23 These evolutionarily con-
served, cell-autonomous, biological clocks enable organ-
isms to both anticipate, and adapt to, important
environmental changes, aiding in their survival. In
circadian studies, zeitgeber (ZT) measurements identify
the time from the start of the rhythm to the end of the
daily oscillation. In most cases, ZT times coincide with
the number of hours after light exposure. For example,
ZT12 refers to 12 hours after light exposure.
In the intestine, circadian rhythms regulate digestion,
including gastric acid production, gut motility and nutrient
absorption. Circadian rhythms also affect intestinal stem
cell regeneration and mucosal immunity.24-28 Moreover,
the microbiota composition and functions depend on the
time of day (Figure 3), giving rise to changes in suscepti-
bility to disease. In this review, we discuss the changes in
microbial composition and functions associated with circa-
dian rhythms. We also discuss the mechanistic interactions
between the microbiota and the immune system, and how
they cross-modulate daily oscillations. We highlight various
associations that require further investigation, which will
greatly enhance our knowledge and understanding of the
cross-regulation between microbiota, the immune system
and circadian rhythms.
MICROBIAL RHYTHMS ARE INFLUENCED BY
NUTRIENTS AND THEIR AVAILABILITY
Similar to immune cells (discussed in the other review
articles within this commissioned review series), the
microbiota exhibit circadian rhythms, which modulate
many important functions in the host (Figure 3). The
microbial circadian dynamic is strongly associated with
food intake and thus nutrient availability. In response to
dietary glycans, Firmicutes thrive; however, once these
glycans have been metabolized, Firmicutes decline in
abundance, allowing Bacteroidetes and Verrucomicrobia
to expand in response to accessible host glycans.29-31
These microbial rhythms promote metabolic homeostasis
and can be modulated by food availability, which influ-
ences susceptibility to metabolic diseases, as discussed
next.
Environment
AgeCircadian rhythm
Exercise
Microbiota composition
Disease/infection
GenderDiet
Genetics
TherapyImmune responses
Figure 1. Factors influencing microbial composition. There are many factors which can alter microbial composition. Some factors can also mod-
ulate microbial composition and circadian rhythms, as discussed in this review.
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Time of food consumption drives microbial
rhythmicity
In most laboratory animal facilities, mice are housed in
12-hour light/dark cycles with food ad libitum. In these
conditions, mice consume most of their food in the dark
cycle, when they are most active.32 The composition of
the caecal microbiota in mice, maintained under these
conditions, changes dynamically in a cyclical manner, as
shown by the microbial 16S rRNA sequence.33 Zarrinpar
and colleagues found that the relative abundance of
RORE
Bmal1
Nfil3
ROR
Dbp
Dec1&2
Cry1&2
Per1-3
Rev-erbb
Rev-erba
Clock-
nPas2
Bmal1
Nfil3
DNA
DNA
Figure 2. Circadian rhythm gene regulations. Initiation of the circadian rhythm requires activation of the circadian locomotor output cycles pro-
tein kaput (Clock), brain and muscle ARNT-like 1 (Bmal1) and neuronal PAS domain-containing protein 2 (nPas2) genes. These proteins regu-
late the expression of multiple genes – period circadian protein homologue 1, 2 and 3 (Per1-3), cryptochrome 1 and 2 (Cry1 and Cry2), Rev-erba
(Nr1d1), Rev-erbb (Nr1d2) and differentially expressed in chondrocytes protein 1 and 2 (Dec1 and Dec2). These proteins then repress the tran-
scription of the Clock, Bmal1 and Npas2 genes, as well as their own transcription. Furthermore, D-site of albumin promoter (Dbp) enhances
transcription of clock genes, while nuclear factor, interleukin 3 regulated (Nfil3, also known as E4 bp4), suppresses clock gene transcription. Reti-
noic acid receptors (ROR) can promote Bmal1 and Nfil3 transcription from the ROR response elements (RORE). Red lines = gene activation;
black lines = gene repression.
Fine-tuning of central clock e.g. food
intake/fasting, body temperature
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Figure 3. Importance of microbial oscillations on microbial functions. Microbial oscillations provide an important feedback system to both cen-
tral and peripheral clocks through the oscillations in microbial metabolites, which help to fine-tune the oscillations and ensure the host can
respond more quickly to environmental changes. The oscillations in microbiota are also important for modulating their own functions including
chemotaxis, motility, adherence, DNA repair and metabolism. The oscillations in microbiota and their metabolites are also vital for the fine-tun-
ing of immune responses. Oscillations in microbial ligands recognized by pattern recognition receptors (PRRs) are likely to result in differences
in the strength of stimulation. Changes in microbial oscillations also strongly influence vaccine and therapeutic efficacy through modulating the
immune functions at different times of day including antibody responses, cytokine responses, metabolic responses and homing of immune cells.
Synchronization of therapy to the microbial rhythms is likely to provide the greatest efficacy, limiting susceptibility to infections and disease
development.
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species belonging to the phylum Firmicutes peaked dur-
ing the feeding period and was reduced during fasting,
while species belonging to the phyla Bacteroidetes and
Verrucomicrobia showed opposite trends (peaking during
fasting and reducing when feeding).33 Similar changes
have been reported by others.30,31 Variations in microbial
abundance are also associated with alterations in micro-
bial functions. In the light phase, microbial pathways
associated with chemotaxis and motility, which are
important for microbiota to adhere to the intestinal wall,
are increased.30,34 In contrast, in the dark phase, pathways
related to growth, DNA repair and energy metabolism are
increased, which benefit the host by the production of
growth factors including vitamins. These studies in mice
indicate that microbially produced molecules can modu-
late immunity, as discussed later. Food restriction studies
in mice, limiting food availability to either the light or
dark cycle, have demonstrated that these microbial oscil-
lations are similarly induced by food intake, regardless of
whether in the light or dark cycle.30 Therefore, food avail-
ability and time of consumption drive microbial rhyth-
micity.
High-fat diet
Diet can modulate gut microbiota composition in
humans.35-37 One of the most studied diets is a high-fat
diet, which alters the gut microbiota composition, pro-
moting obesity and metabolic dysfunction in mice and
humans.38-42 In mice, a high-fat diet induces blunted
microbial diurnal rhythmicity, compared with standard
chow-fed mice.33,42 Interestingly, time-restricted feeding
of mice on high-fat diet restored cyclical microbial rhyth-
micity and was able to protect from diet-induced obesity
and metabolic disease.32,33 Importantly, in humans with
metabolic disease or obesity, restricting food intake to 8-
12 hours per day resulted in weight loss and improved
metabolic parameters.43-46 It is unknown whether, as
observed in the mice, the gut microbiota in these individ-
uals was similarly altered; however, a recent study showed
that the microbiota in individuals with obesity and type 2
diabetes had altered rhythmicity.47 Subsequent metage-
nomic analysis identified key altered microbial pathways,
which associated with the clinical metabolic features of
type 2 diabetes (e.g. fasting blood glucose, insulin resis-
tance, HbA1c). Thus, the altered microbial functions
could be used to predict the risk of disease development.
Together, these studies highlight the importance of
microbial circadian rhythms, and how they modulate dis-
ease in humans.
HOST FACTORS ALTER MICROBIAL RHYTHMICITY
Microbial rhythmicity is strongly influenced by nutrient
availability. However, when nutrients were administered
only intravenously to mice (no oral intake), microbial
rhythmicity was still observed,42 suggesting that host
metabolic factors/rhythms, in turn, can also impact
microbial rhythmicity. Many host functions are modu-
lated by the circadian rhythm, including the secretion of
hormones such as glucocorticoids and neurotransmitters,
as well as immune regulation.48,49 Importantly, immune
cells express cell-autonomous circadian rhythms.50-53 Cir-
cadian rhythms alter immune cell differentiation, such as
Th17 cell differentiation, which is regulated by Rev-erba-
driven repression of the Rorct promoter via Nfil3.54 Hom-
ing receptors for immune cells, including CCR7, sphin-
gosine-1-phosphate receptor 1, IL7-R and CXCR4, are
also modulated by circadian rhythms driven by the host
glucocorticoids.55-58 Thus, the circadian rhythm influ-
ences both innate and adaptive immune cell migration at
different times of day. Together, these circadian rhythm-
modulated immune influences protect the host from dis-
ease development. As mentioned earlier, microbiota oscil-
late and thus may impact immune functions. For
example, Th17 cells can be induced by segmented fila-
mentous bacteria (SFB),59 which are members of the daily
oscillating Firmicutes phylum.30,31,33 Furthermore, micro-
biota can modulate intestinal epithelial cell (IEC)-intrinsic
Nfil3 circadian rhythms via type 3 innate lymphoid cells
(ILC3).23 These observations suggest that microbial oscil-
lations not only influence immune development, but also
alter the amplitude of the type of immune responses.
Thus, further understanding of circadian influences on
host:microbial interactions is important.
Host circadian factors modulate microbial
rhythmicity
Mice deficient in key circadian rhythm genes, including
Bmal1 or Per1/2, have disrupted microbial rhythmicity
and composition.30,31 In addition, Clock gene mutant
mice, which encode a dominant negative allele (D19) that
alters the period, precision and persistence of circadian
rhythms, also exhibit changes in microbial richness and
diversity in the stool microbiota.60 These studies have
demonstrated that the host circadian machinery influ-
ences microbial oscillations and composition; however,
reciprocally, microbiota modulate host circadian rhythms.
A comparison between GF (no microbiota present) and
specific pathogen-free (SPF; microbiota present but free
of specific pathogens) mice confirmed that microbiota
induce significant diurnal host circadian rhythms in liver
hepatocytes.42 Interestingly, time-restricted feeding can
restore cellular circadian rhythms in Cry1/2-deficient and
liver-specific Bmal1 and Rev-erba/b-deficient mice, pre-
venting the development of metabolic syndrome and obe-
sity.61 While microbial rhythms were not investigated in
this study, it is likely that they were also altered. Thus,
the crosstalk between microbiota and the host clock is
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important and together influences a number of systemic
effects in the host, including fine-tuning peripheral circa-
dian rhythms.
Androgens modulate microbial composition and
rhythmicity
Some diseases have sex biases,62 suggesting androgens
modulate disease development. In both mice and
humans, androgens modulate the gut microbiota compo-
sition.31,63-65 Interestingly, mouse studies showed that the
gut microbiota modulate androgen metabolism,66 suggest-
ing two-way crosstalk. Androgens also modulate micro-
bial oscillations. Liang and colleagues31 found more
significant diurnal oscillations in female mice compared
with the male mice. Furthermore, there were sex-depen-
dent differences in microbiota composition in Bmal1-de-
ficient mice.31 Sex differences also influence the circadian
period and behaviour, including entrainment to light and
food.67 Importantly, sex modulates circadian influences
on many host physiological functions including blood
pressure, body temperature and adrenal functions.68-70
Thus, it is imperative that any general conclusions,
related to circadian influences, should be drawn from
studies of both sexes in animals and humans, especially if
a sex bias exists for the disease.
CIRCADIAN MODULATION OF HOST PATTERN
RECOGNITION RECEPTORS
Pattern recognition receptors (PRRs) are expressed on a
wide variety of cells. These recognize conserved molecular
structures that are shared by both pathogens and com-
mensal microbes alike, and are known as pathogen-asso-
ciated molecular patterns (PAMPs).71 Through PRR
signalling, the immune system is able to respond to
microbial cues to regulate immunity. However, as dis-
cussed below, PRRs are also influenced by circadian
rhythms (Figure 4), which can have important therapeu-
tic effects, for example in the induction of vaccine-in-
duced immunity, as discussed later.
Circadian modulation of Toll-like receptor expression
Toll-like receptors (TLRs) are the most commonly stud-
ied family of PRRs, found both at the cell surface and
within intracellular endosomes. Each TLR recognizes dif-
ferent PAMPs, including bacterial/viral DNA (unmethy-
lated cytosine-phosphate-guanine (CpG) dinucleotides72),
lipopolysaccharides (LPS73) and viral RNA.74 While
innate immune receptors prevent pathogen infection, they
also have profound beneficial and detrimental impacts on
the adaptive immune system, in both health and disease.
This dichotomy is context-dependent and has been
observed in cancer, autoimmune and metabolic diseases,
as reviewed elsewhere.11,75-78 While the effects of TLR sig-
nalling can be variable, depending on the disease and
model studied, it is clear that TLRs are important
immune targets for therapy.
TLR expression and activation occur in response to
microbial cues and can be modulated by circadian
rhythms, resulting in important functional differences in
responses to microbes, at different times of day. TLR
expression oscillates in macrophages, dendritic cells, B
cells, T cells and non-hematopoetic cells such as
IECs.23,28,50,79,80 In macrophages, Silver and colleagues
showed that different TLRs oscillate and peak at varying
times; for example, the expression of Tlr2 and Tlr6
peaked at ZT19, while Tlr4 peaked earlier at ZT15.50 As
TLR2 can dimerize with TLR6,81 it is not surprising that
these are co-regulated to peak at the same time, whereas
TLR4 is a homodimer and independently regulated and
peaks at a different time. TLR4, however, binds to
CD14,82 a co-receptor. It is currently unclear whether
coreceptors of PRRs, like CD14, are also regulated in a
circadian manner. Furthermore, to our knowledge, there
have been no studies correlating the rhythms of the
microbiota with the abundance of microbial products
that could activate PRRs. However, disruption to the gut
microbiota by antibiotic treatment can dysregulate micro-
bial rhythms, altering host circadian rhythms and TLR
expression.23,28,34
Mukherji and colleagues found that the depletion of
gut microbiota in mice resulted in reduced microbial
recognition by TLRs, which dysregulated the IEC circa-
dian clock.28 This increased ileal corticosterone produc-
tion, altered glucose homeostasis and induced the
development of prediabetes. Subsequently, Wang and col-
leagues found that microbial regulation of the IEC circa-
dian clock was not directly mediated through the IEC.23
Previous studies had identified a subepithelial intestinal
signalling relay, whereby bacterially mediated TLR activa-
tion of DCs induced the secretion of IL-23, which in turn
activated ILC3 cells to secrete IL-22 and modulate IEC
gene expression.83,84 Wang and colleagues further con-
firmed that this DC-ILC3-IEC circuit was required for
modulating IEC circadian rhythms (Rev-erba and Nfil3)
and that the microbiota influenced the amplitude of the
circadian rhythms in IECs through STAT3.23 Together,
these data suggested that symbiosis between the micro-
biota and IEC requires intact circadian oscillations and a
complex interplay between many cell types, which we are
only beginning to decipher.
Circadian modulation of other PRRs
In addition to TLRs, other PRRs, including the nucleotide
oligomerization domain-containing protein 2 (Nod2)28,85
and the nod-like receptor pyrin domain-containing 3
(Nlrp3) protein, a component of the inflammasome, also
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oscillate. Both Nod2 and Nlrp3 can be activated by bacte-
rial products, regulating the secretion of IL-1b and IL-
18.86-88 Interestingly, in mice and humans, circadian
oscillation of Nlrp3 is dependent on Rev-erba.89,90 In
mice, Rev-erba repressed Nlrp3 transcription by specifi-
cally binding to the promoter region.90 Inflammasome
components modulate responses to infections, as well as
alter susceptibility to autoimmunity, neurological and
metabolic diseases and cancer.91-95 Thus, further investi-
gating the mechanisms of circadian modulation of PRRs
may prove beneficial for therapy in a broad range of dis-
eases.
MICROBE-DERIVED METABOLITES AND
CIRCADIAN RHYTHMS
As microbiota composition and functions oscillate in a
circadian manner, metabolites from gut microbiota34 in
both mice and humans also exhibit circadian varia-
tions.96-100 Thaiss and co-authors showed that antibiotic
depletion of the microbiota led to the loss of microbial
diurnal rhythmicity in mice.34 In addition, they also
found that the microbiota-induced oscillations in serum
ornithine and polyamines could be induced by time-re-
stricted feeding, in a host that had deficient circadian
rhythm (Per1 and Per2 knockout mouse). Together, these
data provided pivotal evidence that microbiota modulate
the host circadian metabolome. While this study did not
investigate the impact of microbiota and their metabolites
on host immunity, there are many potential implications
for the immune system, especially mucosal immunity.
The gut microbe-derived short-chain fatty acids
(SCFAs), butyrate, acetate and propionate, modulate
immune responses, including the induction of Tregs.101-
103 Interestingly butyrate, which is absent in germ-free
mice, modulates Per2 and Bmal1 rhythms, suggesting that
the microbiota indirectly regulate circadian rhythms via
their metabolites.42 These SCFAs typically bind to the G
protein-coupled receptors (Gpr) 41/43,104,105 although
other receptors also bind to SCFAs.106 Many types of host
cells utilize SCFAs, and these promote deletion of autore-
active T cells and anti-inflammatory responses in models
of colitis, arthritis, type 1 diabetes and asthma.104,107,108
SCFA utilization can also restrict tumour growth and sur-
vival.109-111 Importantly, the effect of SCFAs on some
cells, such as monocytes, may not always elicit the same
responses from mice and humans.112 For example, activa-
tion of human monocytes with acetate induced attenu-
ated proinflammatory responses; however, activation of
mouse monocytes (on the 129/SvEv background) with
acetate promoted elevated proinflammatory GM-CSF, IL-
1a and IL-1b cytokine secretion.112 Given that mouse and
human monocytes respond differently to acetate, it is
possible that additional regulators of SCFA utilization,
Microbial
ligands/
metabolites
Immunity to
bacteria, viruses
parasites and fungi
CytokinesPRRs
Nfil3
Rora
Rev-erba
STAT3
Lipid
uptake
PPARα
Bmal1:Clock
Per:Cry
Figure 4. Microbial modulation of circadian rhythms. PRR oscillation (referring to published work in TLRs and Nlrp3) is driven by competition
between the Rev-erba repressor and the Rora activator, both of which directly bind and compete for the ROR response element, a DNA binding
sequence, present in Bmal1. This competition promotes the oscillation of antimicrobial responses, for example cytokines, which are mediated by
downstream NFjB and AP-1 binding to target genes. Bmal1 binds to an Ebox element (a DNA sequence) in Rev-erba activating its transcription,
while a DR2 element (another DNA sequence) in Rev-erba mediates its autorepression and activation by PPARa. DNA elements (RORE, Ebox,
Dbox – not shown) are present in TLR genes, Nod2, circadian genes and many other genes, including many which influence immune processes.
Circadian regulation of Nfil3 by the Rev-erba repressor and the Rora activator can also modulate intestinal lipid absorption and transport23.
Another mechanism of circadian regulation of TLRs has also been identified in peritoneal macrophages, whereby Tlr9 expression is controlled by
direct binding of Bmal1 to the Ebox sequence present in the Tlr9 gene80. Red lines indicate activation; black lines indicate inhibition. Blue boxes
indicate the known effects of microbiota in modulating circadian rhythms.
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and the rhythms that modulate them may vary between
species. SCFAs such as butyrate can also regulate the
integrity of the intestinal barrier by stabilizing hypoxia-in-
ducible factor (HIF).113,114 Interestingly, HIFa regulates
several core clock genes, allowing the cells to respond to
changes in oxygen.115 This has implications, for example,
for induction of tumour hypoxia in cancer therapy. Given
that microbial metabolites oscillate, there may be similar
oscillations in their respective SCFA receptors, or in pro-
teins regulating the downstream responses.
Bile metabolism is also regulated in a time-of-day-de-
pendent manner due to the need to co-ordinate meta-
bolic responses to food intake, enabling the esterification
and absorption of dietary fats and lipids.116,117 In mice,
the serum bile acids peak at the beginning and end of
their active (dark) phase. The majority of bile acids are
reabsorbed by the liver; however, some can enter the
colon and be further metabolized, producing secondary
metabolites that peak in the serum at the beginning of
the dark phase.118,119 Many species belonging to the phyla
Firmicutes and Bacteroidetes encode enzymes required to
metabolize bile acids, for example bile salt hydrolases.
These enzymes regulate hepatic and ileal clock genes and
lipid and cholesterol metabolism.116,117,120 Interestingly,
the intestinal epithelium receptor, CD300lf, has been
identified to be the receptor for mouse norovirus.121 This
CD300lf receptor undergoes structural changes upon
binding to the bile acid, glycochenodeoxycholic acid,
which consequently enhanced the ability of norovirus to
bind to the receptor.122 Recent studies have shown that
microbiota can modulate the ability of mouse norovirus,
a highly contagious viral pathogen, to infect the host.123
Furthermore, crosstalk between mouse norovirus and the
microbiota can alter susceptibility to autoimmunity,124-
126, parasitic infection127 and allergies.128 As bile acids can
be modulated in a circadian manner, it is also possible
that invasion of norovirus may be enhanced at different
times of the day.
In addition, microbiota synthesize a range of other
molecules including xenobiotics, vitamins, polyamines
and hydrogen sulphide. Little is known about how circa-
dian rhythms modulate their production and impact on
the immune system. Investment in this area would aid
our understanding of their important role in health and
disease.
IMPACT OF CIRCADIAN MICROBIAL
OSCILLATIONS ON IMMUNITY TO INFECTIOUS
ORGANISMS
Circadian rhythms, and their regulation, have an impor-
tant influence on susceptibility to invading pathogens.
Bellet and colleagues showed that the immune responses
to Salmonella Typhimurium (a common foodborne
pathogen) in infected mice were dependent on the time
of day.129 The mice infected in the active phase (ZT16)
had reduced pathogen colonization and reduced inflam-
mation, compared with mice infected in the rest phase
(ZT4).129 Host circadian rhythms are required for this
response, as Clock mutant mice exhibited arrhythmic col-
onization and their macrophages had reduced inflamma-
tory responses (IL-6 and IL-1b) to LPS (recognized by
TLR4, which is known to oscillate23,28,50,79,80). Similarly,
in wild-type mice, S. pneumoniae-induced infection at
ZT12 resulted in earlier neutrophilia in the bronchoalveo-
lar lavage fluid, with reduced local (lung) and systemic
(blood) bacterial counts at 48 hours post-infection, com-
pared with infection at ZT0.130 In addition, intraperi-
toneal infection with Listeria monocytogenes confirmed
that a later rest phase infection at ZT8 was important for
enhanced recruitment of Ly6Chi monocytes and stronger
antimicrobial immunity, compared with infection at the
start of the rest phase ZT0.53 Similar time-of-day-depen-
dent sensitivities to viral infections have also been
reported.131-133 Interestingly, parasitic infection of mice
by oral gavage of Trichuris muris eggs at ZT0 led to
enhanced anti-parasitic IgE titres, Th2 responses and
worm expulsion, compared with the mice infected at
ZT12, the end of the rest phase.134 Thus, the optimal
immune responsive time to pathogens is not the same for
all micro-organisms. The different time-dependent oscilla-
tions in pattern recognition receptors, or microbial
metabolites, influence immune responsiveness. Therefore,
priming the immune system at the time of greatest
immune responsiveness would be vital for preventing and
limiting the spread of specific infectious organisms. To
date, it remains unknown as to whether the immune
responses to these infectious organisms can be modulated
by the commensal microbiota and whether the commen-
sal microbial circadian rhythms are altered in pathogenic
infections, which in turn subsequently change the host
response. It is clear that further studies are required, espe-
cially when multiple factors are analysed in the same
study.
APPLICATIONS OF KNOWLEDGE OF MICROBIAL
CIRCADIAN RHYTHMS TO THERAPY
The microbiome is an important metabolic ‘organ’, aid-
ing in many unique host functions, which include the
efficacious response to a number of therapies. It is well
established that the microbiome influences susceptibility
to obesity. Microbiota from obese individuals can transfer
metabolic dysfunction to another host, while the micro-
biota from lean individuals, following transfer, protect the
recipient from metabolic dysbiosis.38,135,136 Metformin, a
widely used drug for the treatment of type 2 diabetes,
improves insulin sensitivity. Metformin alters both the
composition and the function of microbiota, enhancing
the therapeutic effects.137 However, components of the
ª 2020 The Authors. Immunology published by John Wiley & Sons Ltd, Immunology 7
gut microbiota can also be harmful, depending on the
context. In colorectal cancer, the intestinal microbiota
can influence disease progression138-140 or aid the thera-
peutic responses to both chemotherapeutics141,142 and
immune checkpoint inhibitors, for example CTLA-4, PD-
1, PD-L1.13,143,144 Therefore, understanding the mecha-
nisms by which specific microbiota exert their effects (e.g.
circadian modulation) could improve therapeutic success.
In an animal model of colorectal cancer, induced by
azoxymethane and dextran sulphate sodium, Mager and
colleagues identified 3 species of tumour-associated bacte-
ria (Bifidobacterium pseudolongum, Lactobacillus johnsonii
and Olsenella sp.) which enhanced immune checkpoint
blockade therapy.145 This enhancement of therapy was
orchestrated predominantly by the microbial production
of inosine, which binds to the adenosine A2A receptor,
promoting Th1 differentiation in the presence of IFN-c
and consequently anti-tumour effects. Of note, Lactobacil-
lus johnsonii belongs to the phylum Firmicutes, the abun-
dance of which is known to oscillate daily.30,31,33
Lactobacillus johnsonii is also associated with modulating
immunity and preventing autoimmune diabetes.146-148 In
a recent study assessing metabolism of 271 orally admin-
istered drugs by 76 different human gut bacteria, the
authors reported that the microbiota can metabolize
many more drugs than previously known.149 In addition,
the drug-metabolizing function of the microbiota has
both local intestinal effects and important systemic
effects, especially on the liver. Hepatic drug metabolism is
also influenced by circadian rhythm.150-152 Thus, circa-
dian microbial oscillations (whether through direct or
indirect mechanisms) are likely to modulate the ability to
metabolize drugs and therefore may have important ther-
apeutic impacts. It should also be noted that peripheral
circadian rhythms are often tissue-specific, and therefore,
microbial rhythms could be out of synchrony with the
rhythms in different tissues.17,18 This may potentially arise
due to the presence of dysbiotic microbiota or stronger
peripheral circadian inducers. Thus, it is critically impor-
tant to identify novel pathways regulating the peripheral
rhythms, which are influenced by the microbiota, and
synchronize these rhythms, for maximal clinical benefits.
The types of gut microbiota that adhere to the intesti-
nal wall may also oscillate and can play an important role
in intestinal immunity. Akkermansia muciniphilia, a
mucin-degrading commensal bacteria belonging to the
Verrucomicrobia phylum,153 is protective against ulcera-
tive colitis,154-156 type 1 diabetes157-159 and obesity.160
Furthermore, Akkermansia muciniphilia improves thera-
peutic efficacy in cancer patients who are treated with
immune checkpoint blockers.13 Given the oscillation in
abundance of Verrucomicrobia,30,31,33 appropriately tim-
ing therapeutic administration of these bacteria may
enhance efficacy. As discussed earlier, it is important to
note that bacteria can be beneficial or harmful, depending
on the context. Akkermansia muciniphilia, while beneficial
in the aforementioned studies, can also promote T-cell-
mediated inflammation in multiple sclerosis161 and thus
microbial therapies need to be tailored appropriately.
Microbial circadian rhythms modulate long-term
immunity following immunization and vaccination.
Microbiota composition can modulate vaccine efficacy to
bacteria and viruses in both animal models162-164 and
humans.165-168 Evidence for this has been obtained from
vaccine studies conducted in GF, as well as antibiotic-
treated mice, resulting in impaired antibody
responses.162,163 Similarly, in humans, administration of
broad-spectrum antibiotics also reduced the immuno-
genicity of the rotavirus vaccine.167 Rhythmic microbial
and PRR rhythms are also likely to influence vaccine effi-
cacy, although this remains to be studied. Host circadian
genes can also alter the vaccine efficacy. Per2, one of the
major circadian gene family members,169 controls TLR9-
mediated innate and adaptive immune responses to infec-
tion and sepsis.80 Moreover, Per2 also controls vaccine
immune responses to TLR9 ligand-adjuvanted immuniza-
tion using CpG (a bacterial DNA, which is a TLR9 ligand
and a common vaccine adjuvant72).80 These studies have
provided evidence for a vital link between circadian
rhythms and TLR signalling, which promotes enhanced
vaccine efficacy. Furthermore, in Cry1/Cry2 double
knockout mice, there are more circulating mature B cells
that secrete higher titres of antibodies to T-cell-indepen-
dent antigenic stimulation (4-hydroxy-3-nitrophenyl-
acetyl (NP)-conjugated Ficoll).170 This again highlights
host rhythms influencing immunity. Oscillations in anti-
body responses have also been seen in other studies,
including vaccination studies.56,171-174 A randomized trial
investigating the efficacy of the trivalent inactivated influ-
enza virus demonstrated that vaccine administration in
the morning induced higher antibody titres than in the
afternoon173; however, the oscillating antibodies post-vac-
cination are likely to be viral strain-specific171 and influ-
enced by sex.172 As TLR9 is highly expressed on B cells175
and requires downstream MyD88 signalling to mediate
functional changes,176,177 it is likely that oscillating TLR9
levels may influence B-cell antibody responses; however,
this has yet to be fully investigated. This also applies to
autoantibody production, which can be regulated by TLR
expression.178-180 Murine studies, in which peptide
immunization was performed at different times of day,
showed that this influenced both T-cell immunity and
susceptibility to disease.56,181,182 Furthermore, immune-
intrinsic circadian rhythms were vital for this effect.56,182
Thus, both Bcell and Tcell responses to antigen can be
modulated by circadian rhythms. Further understanding
of how the microbial rhythms may influence antigen-
specific immunity may prove even more beneficial.
While the role of microbiota-mediated modulation of
host immunity using antibiotic treatment or GF mice has
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been extensively studied, the impact of pro- or pre-biotics
or bacteriophages (bacteria-targeting viruses) on either
host or microbial circadian rhythms is not currently
known. Studying bacteriophages and their role in modu-
lating microbial circadian rhythms may therefore also
prove to be an important research field, particularly as
bacteriophages can adhere to the mucus layer and prevent
infection from pathogenic bacteria.183,184
CHALLENGES IN STUDYING MICROBIAL
RHYTHMICITY
Reporting microbial rhythmicity
A common challenge facing researchers studying the
microbial rhythmicity lies in the interpretation and pre-
sentation of the data. Relative microbial abundance is
often reported in microbial circadian oscillation studies,
referring to the proportion of specific bacteria within the
total bacteria sequenced. However, this can potentially
under- or over-estimate changes in the microbiota com-
position and thus the inferred absolute microbial abun-
dance is sometimes used. The inferred absolute microbial
abundance is determined by multiplying the 16S rRNA
copy number by the relative abundance within a given
sample. Studies using different methods could lead to dis-
crepancies between different reports of the abundance of
bacteria which oscillate at different times of day. For clar-
ity, we suggest that the reporting of these microbial
rhythms should be presented both ways. An alternative
method would be to conduct both microbial sequencing
and a culture-based approach (on selective media) to
identify numbers of specific bacteria; however, this
approach is not infallible as most gut bacteria cannot be
cultured. Further developments are needed in this area
before true microbial counts for all bacteria can be deter-
mined.
Limited studies in both sexes
As previously mentioned, sex influences the microbial
composition and rhythmicity. While some studies do
investigate sex biases, many more do not. Thus, studies
should be conducted in both males and females to iden-
tify the role of androgens/oestrogens in modulating circa-
dian rhythms.
Evaluating all variables
There are many factors, already discussed, that can influ-
ence microbial composition and circadian rhythms,
including light, diet, therapies (e.g. antibiotics), genetics,
hormones, sleep patterns, behaviour and disease develop-
ment. In many studies, it is difficult to investigate all
variables; however, in mice, many of these can be con-
trolled but not all are studied. This is the same in human
studies, where food intake is restricted44-46 but exercise,
genetics, light exposure, among other factors, are not
considered. While these studies highlight the importance
of circadian rhythms in health and disease, future studies
need to consider additional factors and their contribu-
tion, if any, to the results obtained. Larger study cohorts
and controlled facilities, where all participants reside and
are maintained in the same light cycles and on the same
diet, are likely to be required.
SUMMARY
In this review, we have discussed time-of-day-dependent
differences in the microbiota and how they may impact
host metabolism and immunity. While it is known the
microbiota are associated with the development and pro-
gression of many diseases, little is known of the influence
that circadian oscillations have on the microbiota, which
may also modulate disease susceptibility. We hope to
have provided insight into some potential future direc-
tions in relation to microbial oscillations and how they
can directly, or indirectly, regulate host immune
responses in different disease settings. Given the signifi-
cant influence that circadian rhythms have on host
immunity, it is important that more studies consider the
timing of experiments and administration of therapies. By
better understanding circadian influences, we may maxi-
mize clinical success by targeting the cells/microbiota of
interest, at the time they are most vulnerable. This could
potentially enable reduced drug concentrations to be
used, which would also limit toxic effects. Understanding
these rhythms in both males and females is vital, given
the importance of androgens in immunity and in shaping
the host microbial communities. While the vast majority
of work outlined in this review has focused on microbiota
in the gut, it will also be important to study the circadian
effects on microbiota in different locations that include
the skin, lungs, as well as other mucosal surfaces. It is
likely that most commensal microbiota, in these different
locations, modulate immunity in a time-of-day-depen-
dent manner. This is a continually expanding new field
and we look forward to gaining further insight, which
may improve efficacy of current, as well as new therapies,
for disease prevention and treatment.
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